Bacteria News and Research

RSS

Scientists discover how bacteria invade heart tissue and cause endocarditis

Scientists have discovered the tool that bacteria normally found in our mouths use to invade heart tissue, causing a dangerous and sometimes lethal infection of the heart known as endocarditis.

28 Jun 2011

Bdellovibrio safe and effective for treating Salmonella infection

Scientists have tested a predatory bacterium - Bdellovibrio - against Salmonella in the guts of live chickens. They found that it significantly reduced the numbers of Salmonella bacteria and, importantly, showed that Bdellovibrio are safe when ingested.

28 Jun 2011

Australian Nobel Prize winner closer to delivering vaccines in food after positive first study in humans

The Australian scientist who won a Nobel Prize for identifying a cancer-causing stomach bacterium, today said a clinical trial had shown that some strains of the bacteria (Helicobacter pylori or H. pylori) were safe and well tolerated in humans.

27 Jun 2011

Researchers identify new component of plague causing bacterium that can be used as a vaccine

Researchers from the Smiley lab at the Trudeau Institute have now identified a single component of the plague causing bacterium that can be used as a vaccine. This single "subunit" could potentially be used to create a safer form of a T cell-stimulating plague vaccine. The new data is featured in the July issue of The Journal of Immunology.

27 Jun 2011

Woods Institute at Stanford University awards seven new Environmental Venture Project grants

The Woods Institute for the Environment at Stanford University has awarded seven new Environmental Venture Projects (EVP) grants for interdisciplinary research aimed at finding practical solutions promoting global sustainability.

24 Jun 2011

Protein globin E helps avian eyes 'breathe' and contributes to visual acuity

Say what you will about bird brains, but our feathered friends sure have us -- and all the other animals on the planet -- beat in the vision department, and that has a bit to do with how their brains develop.

24 Jun 2011

Discovery sheds new light on initiation of vision process

A discovery by a team of researchers led by a Syracuse University physicist sheds new light on how the vision process is initiated. For almost 50 years, scientists have believed that light signals could not be initiated unless special light-receptor molecules in the retinal cells first changed their shape in a process called isomerization.

24 Jun 2011

Migratory birds play a key role in global spreading of tick-borne disease

The most common tick-borne disease in humans is Lyme borreliosis. Extensive field and laboratory tests have revealed that the Borrelia bacterium is present in a larger proportion of ticks than has been shown by earlier studies.

24 Jun 2011

New York Times examines very rare E. coli strain responsible for German outbreak

The New York Times examines the E. coli strain responsible for the recent outbreak in Germany, saying the bacteria "have a highly unusual combination of two traits and that may be what made the outbreak among the deadliest in recent history, scientists there are reporting."

24 Jun 2011

Copenhagen chemist reveals mechanism behind deadly infections

Anthrax, septicemia and meningitis are some of the planet's most deadly infections. In part because doctors lack basic insights to prevent and cure diseases caused by so called Gram-positive bacteria. Now, a chemist from the University of Copenhagen has revealed the mechanism behind these deadly infections.

24 Jun 2011

Veredus Labs develops ‘Lab-on-Chip’ to detect and differentiate several food-borne pathogens, including Escherichia coli

Veredus Laboratories, a leading provider of molecular detection tests, and its technology partner, STMicroelectronics (NYSE: STM), today announced the successful development and deployment of VereFoodborne™, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, including the Shiga toxin-producing Escherichia coli (E. coli) responsible for the recent severe food poisoning outbreak in Europe.

23 Jun 2011

Veredus Lab-on-Chip application can diagnose and differentiate food-borne pathogens

Veredus Laboratories, a leading provider of molecular detection tests, and its technology partner, STMicroelectronics, today announced the successful development and deployment of VereFoodborne, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, including the Shiga toxin-producing Escherichia coli responsible for the recent severe food poisoning outbreak in Europe.

23 Jun 2011

Sungwon president signs consent decree of permanent injunction for seafood products: FDA

The U.S. Food and Drug Administration announced that Sungwon Inc of Columbia, a Columbia, Md., corporation, and the company's president, Sang Ja Lee, have signed a consent decree of permanent injunction.

23 Jun 2011

LPI receives final FDA approval for generic version of Levaquin tablets

Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market a generic version of Ortho McNeil's Levaquin tablets.

23 Jun 2011

Innovative Nail after Lengthening method can extend short thighbone by 26 centimeters

The MedUni Vienna's University Department of Trauma Surgery at Vienna General Hospital is a leader in the field of treatment of traumatic bone defects caused by accidents. A severely shortened thighbone as the result of an accident has now been able to be extended by using the innovative NAL method, creating an increase of 26 centimetres in only eight months.

22 Jun 2011

New study offers detailed look at the status of Lyme disease in Central Illinois

A new study offers a detailed look at the status of Lyme disease in Central Illinois and suggests that deer ticks and the Lyme disease bacteria they host are more adaptable to new habitats than previously appreciated.

22 Jun 2011

Breakthrough treatment for Cystic Fibrosis sufferers with 'Celtic Gene'

An international research team led by Queen's University have developed a ground breaking treatment for Cystic Fibrosis sufferers. The new drug will benefit sufferers who have the 'Celtic Gene', a genetic mutation which is particularly common in Ireland.

20 Jun 2011

Bacteria News and Research

Scientists discover how bacteria invade heart tissue and cause endocarditis

Bdellovibrio safe and effective for treating Salmonella infection

Australian Nobel Prize winner closer to delivering vaccines in food after positive first study in humans

Researchers identify new component of plague causing bacterium that can be used as a vaccine

Woods Institute at Stanford University awards seven new Environmental Venture Project grants

Protein globin E helps avian eyes 'breathe' and contributes to visual acuity

Discovery sheds new light on initiation of vision process

Migratory birds play a key role in global spreading of tick-borne disease

New York Times examines very rare E. coli strain responsible for German outbreak

Copenhagen chemist reveals mechanism behind deadly infections

Veredus Labs develops ‘Lab-on-Chip’ to detect and differentiate several food-borne pathogens, including Escherichia coli

Veredus Lab-on-Chip application can diagnose and differentiate food-borne pathogens

Sungwon president signs consent decree of permanent injunction for seafood products: FDA

LPI receives final FDA approval for generic version of Levaquin tablets

Innovative Nail after Lengthening method can extend short thighbone by 26 centimeters

New study offers detailed look at the status of Lyme disease in Central Illinois

Breakthrough treatment for Cystic Fibrosis sufferers with 'Celtic Gene'

Ground breaking treatment for Cystic Fibrosis

Women, young people more worried about EHEC bacteria outbreak in Europe

Enterologics to acquire BioBalance from NYHC

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo